XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Oct. 31, 2023   988,782      
Balance at the beginning of period at Oct. 31, 2023 $ (1,069) $ 10 $ 1,505 $ (2,361) $ (223)
Increase (Decrease) in Stockholders' Equity          
Net earnings 622     622  
Other comprehensive income (loss), net of taxes (235)       (235)
Comprehensive income (loss) 387        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,677      
Issuance of common stock in connection with employee stock plans and other (76)   (76)    
Repurchases of common stock (in shares)   (17,062)      
Repurchases of common stock (Note 10) (514)   (27) (487)  
Cash dividends (545)     (545)  
Stock-based compensation expense 177   177    
Balance (in shares) at Jan. 31, 2024   980,397      
Balance at the end of period at Jan. 31, 2024 (1,640) $ 10 1,579 (2,771) (458)
Balance (in shares) at Oct. 31, 2023   988,782      
Balance at the beginning of period at Oct. 31, 2023 (1,069) $ 10 1,505 (2,361) (223)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,229        
Other comprehensive income (loss), net of taxes (109)        
Comprehensive income (loss) $ 1,120        
Repurchases of common stock (in shares) (20,500)        
Balance (in shares) at Apr. 30, 2024   977,507      
Balance at the end of period at Apr. 30, 2024 $ (916) $ 10 1,663 (2,257) (332)
Balance (in shares) at Jan. 31, 2024   980,397      
Balance at the beginning of period at Jan. 31, 2024 (1,640) $ 10 1,579 (2,771) (458)
Increase (Decrease) in Stockholders' Equity          
Net earnings 607     607  
Other comprehensive income (loss), net of taxes 126       126
Comprehensive income (loss) 733        
Issuance of common stock in connection with employee stock plans and other (in shares)   584      
Issuance of common stock in connection with employee stock plans and other $ (4)   (4)    
Repurchases of common stock (in shares) (3,500) (3,474)      
Repurchases of common stock (Note 10) $ (99)   (6) (93)  
Stock-based compensation expense 94   94    
Balance (in shares) at Apr. 30, 2024   977,507      
Balance at the end of period at Apr. 30, 2024 $ (916) $ 10 1,663 (2,257) (332)
Balance (in shares) at Oct. 31, 2024 939,000 938,989      
Balance at the beginning of period at Oct. 31, 2024 $ (1,323) $ 9 1,778 (2,676) (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 565     565  
Other comprehensive income (loss), net of taxes 230       230
Comprehensive income (loss) 795        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,405      
Issuance of common stock in connection with employee stock plans and other (92)   (92)    
Repurchases of common stock (in shares)   (2,734)      
Repurchases of common stock (Note 10) (97)   (4) (93)  
Cash dividends (547)     (547)  
Stock-based compensation expense 192   192    
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the end of period at Jan. 31, 2025 $ (1,072) $ 9 1,874 (2,751) (204)
Balance (in shares) at Oct. 31, 2024 939,000 938,989      
Balance at the beginning of period at Oct. 31, 2024 $ (1,323) $ 9 1,778 (2,676) (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 971        
Other comprehensive income (loss), net of taxes (409)        
Comprehensive income (loss) $ 562        
Repurchases of common stock (in shares) (5,800)        
Balance (in shares) at Apr. 30, 2025 942,000 942,209      
Balance at the end of period at Apr. 30, 2025 $ (1,276) $ 9 1,999 (2,441) (843)
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the beginning of period at Jan. 31, 2025 (1,072) $ 9 1,874 (2,751) (204)
Increase (Decrease) in Stockholders' Equity          
Net earnings 406     406  
Other comprehensive income (loss), net of taxes (639)       (639)
Comprehensive income (loss) (233)        
Issuance of common stock in connection with employee stock plans and other (in shares)   667      
Issuance of common stock in connection with employee stock plans and other $ (9)   (9)    
Repurchases of common stock (in shares) (3,100) (3,118)      
Repurchases of common stock (Note 10) $ (103)   (6) (97)  
Cash dividends 1     1  
Stock-based compensation expense $ 140   140    
Balance (in shares) at Apr. 30, 2025 942,000 942,209      
Balance at the end of period at Apr. 30, 2025 $ (1,276) $ 9 $ 1,999 $ (2,441) $ (843)